Results 151 to 160 of about 128,907 (343)

Fat taste sensitivity in women with obesity: transcriptomic analysis of fungiform papillae before and after bariatric surgery

Obesity, EarlyView.
Abstract Objective Fat taste sensitivity has been implicated in long‐term weight loss after bariatric surgery. Unexpectedly, improvement of orosensory fat acuity was not systematic in operated patients. Methods Obesity‐induced alterations of gene expression in gustatory papillae having been recently reported, we have explored the fungiform ...
Arnaud Bernard, Corentin Richard, Loredana Radoi, Romain Boidot, Séverine Ledoux, Philippe Besnard   +5 more
wiley   +1 more source

Higher Glycated Hemoglobin Level Is Associated with Increased Risk for Ischemic Stroke in Non-Diabetic Korean Male Adults [PDF]

, 2011
Hyung Geun Oh, Eun‐Jung Rhee, Tae‐Woong Kim, Kyung Bok Lee, Jeong-Ho Park, Kwang-Ik Yang, Dushin Jeong, Hyung-Kook Park   +7 more
openalex   +1 more source

Long‐acting PYY3−36 analogue with semaglutide for obesity: from preclinical assessment through randomized clinical studies

Obesity, EarlyView.
Abstract Objective The hormone peptide YY (PYY; cleaved into Y2‐selective form PYY3‐36) is an attractive candidate for use as a complementary pharmacotherapy for obesity along with glucagon‐like peptide‐1 (GLP‐1) receptor agonists. This series of studies investigated a novel long‐acting PYY3‐36 analogue (PYY1875) alone and as an add‐on to semaglutide ...
Birgitte S. Wulff, Adam Paul Chambers, Cynthia Karenina Osorto Contreras, Katrine Kirkeby, Anders Rasmussen Rinnov, Riia K. Sustarsic, Søren Østergaard, John E. Laabs, Patrick M. O'Neil   +8 more
wiley   +1 more source

Comparing the Metabolic Syndrome Frequency and Components among Inactive College Students Using Standard and Asian Definitions of Body Mass Index

Iranian Journal of Diabetes and Obesity, 2019
Objective: There are changes in plasma glucose and HbA1c of type 2 diabetes mellitus (T2DM) patients in different seasons. HbA1c levels may increase during winter season in most T2DM patients without weight gain.
Majid Gholipour
doaj  

Response to Comment on: Boronat et al. Differences in Cardiovascular Risk Profile of Diabetic Subjects Discordantly Classified by Diagnostic Criteria Based on Glycated Hemoglobin and Oral Glucose Tolerance Test. Diabetes Care 2010;33:2671–2673 [PDF]

, 2011
Mauro Boronat, Francisco J. Nóvoa
openalex   +1 more source

Changes in weight and glycemic control following obesity treatment with semaglutide or tirzepatide by discontinuation status

Obesity, EarlyView.
Abstract Objective The objective of this study was to characterize changes in body weight and glycated hemoglobin (in those with prediabetes at baseline) through 12 months by obesity pharmacotherapy discontinuation status. Methods This retrospective cohort study used electronic health record data from a large health system in Ohio and Florida to ...
Hamlet Gasoyan, W. Scott Butsch, Rebecca Schulte, Nicholas J. Casacchia, Phuc Le, Christopher B. Boyer, Marcio L. Griebeler, Bartolome Burguera, Michael B. Rothberg   +8 more
wiley   +1 more source

Nutritional priorities to support GLP‐1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society

Obesity, EarlyView.
Abstract Background Glucagon‐like peptide 1 receptor agonists and combination medications (hereafter collectively referred to as GLP‐1s) are shifting the treatment landscape for obesity. However, real‐world challenges and limited clinician and public knowledge on nutritional and lifestyle interventions can limit GLP‐1 efficacy, equitable results, and ...
Dariush Mozaffarian, Monica Agarwal, Monica Aggarwal, Lydia Alexander, Caroline M. Apovian, Shagun Bindlish, Jonathan Bonnet, W. Scott Butsch, Sandra Christensen, Eugenia Gianos, Mahima Gulati, Alka Gupta, Debbie Horn, Ryan M. Kane, Jasdeep Saluja, Deepa Sannidhi, Fatima Cody Stanford, Emily A. Callahan   +17 more
wiley   +1 more source

Evaluation of Four Semi‐Mechanistic Models for Predicting Glycemic Control With a Glucagon Receptor Antagonist in People With Type 2 Diabetes

CPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Glycated hemoglobin (HbA1c) is the gold standard for measuring long‐term glycemic efficacy over at least 3 months in Type 2 diabetes (T2D). Being able to predict HbA1c using glucose response from studies of less than 3 months would be useful.
Austin Yue Feng Tan, Karen Schneck, Parag Garhyan, Eric Chun Yong Chan, Lai San Tham   +4 more
wiley   +1 more source

What is the best predictor of mortality in patients with type 2 diabetes and chronic kidney disease: mean, variability of HbA1c or HbA1c-Hemoglobin ratio?

BMC Nephrology
Aim Limitations in the measurement of glycated hemoglobin (HbA1c) in patients with type 2 diabetes (T2D) and chronic kidney disease (CKD) result in uncertainty about the best predictor of mortality among these patients.
Seng-Wei Ooi, Ming-Tsang Lee, Yung-Yueh Chang, Chin-Huan Chang, Hua-Fen Chen   +4 more
doaj   +1 more source

Inappropriately Low Glycated Hemoglobin Values and Hemolysis in HIV-Infected Patients

, 2006
Marie-Emilienne Diop, Jean‐Philippe Bastard, Natacha Meunier, Sandrine Thévenet, Mustapha Maachi, Jacqueline Capeau, Gilles Pialoux, Corinne Vigouroux   +7 more
openalex   +2 more sources